iShares Biotechnology ETF (IBB)
BCBA
Closed
Aug 24, 2026
Day's Range
12,420.0052 wk Range
6,790.00Overview - IBB - iShares Biotechnology ETF
Key Statistics
Valuation
Enterprise Value
22,676.04T
Price / Book
‪193.90‬
EV / EBITDA
‪190.95‬
Profitability
Profit Margin
‪35.54%‬
Operating Margin
‪42.76%‬
Return on Assets
‪17.18%‬
Return on Equity
‪36.13%‬
Ownership
Float
2.17B
Price stats
Beta
‪1.21‬
50-Day Avg
‪11,005.90‬
200-Day Avg
‪9,777.48‬
Dividends
Frequency
Semi-Annual
Peers - IBB - iShares Biotechnology ETF
Peer Comparison
Compared with companies in Asset Management listed on BCBA.
- IBIBBBCBAiShares Biotechnology ETF+45.09%52-week change—P/E (Trailing)‪35.54%‬Profit Margin
- GAMIBCBAGamco Investors, Inc.-2.84%52-week change8.28P/E (Trailing)‪26.34%‬Profit Margin
- EEMBCBAiShares MSCI Emerging Markets ETF CEDEAR+34.89%52-week change23.85P/E (Trailing)‪49.18%‬Profit Margin
- BPCBCBABP p.l.c. CEDEAR+21.79%52-week change—P/E (Trailing)—Profit Margin
- EADBCBAElectronic Arts Inc. - CEDEAR+20.19%52-week change—P/E (Trailing)‪13.80%‬Profit Margin
- COPBCBAConocoPhillips+14.84%52-week change—P/E (Trailing)‪14.40%‬Profit Margin
- BBDCBCBABanco Bradesco S.A. CEDEAR+5.51%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - IBB - iShares Biotechnology ETF
About
iShares Biotechnology ETF is an exchange-traded fund that provides diversified exposure to the U.S. biotechnology industry, tracking a modified market-cap-weighted index of publicly listed biotechnology firms. Its primary function is to pool investments in leading biotech companies, enabling investors to participate…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
